Identification Of Potential Inhibitors Of Cutaneous Melanoma And Non-Melanoma Skin Cancer Cells Through In-Vitro And In-Silico Screening Of A Small Library Of Phenolic Compounds

dc.contributor.authorBoateng, S.T.
dc.contributor.authorRoy, T.
dc.contributor.authorAgbo, M.E.
dc.contributor.authorBanang-Mbeumi, S.
dc.contributor.authorChamcheu, R.-C.N.
dc.contributor.authorBramwell, M.
dc.contributor.authorPham, L.K.
dc.contributor.authorJackson, K.E.
dc.contributor.authorHill, R.A.
dc.contributor.authorNagalo, B.M.
dc.contributor.authorEfimova, T.
dc.contributor.authorFotie, J.
dc.contributor.authorChamcheu, J.C.
dc.date.accessioned2026-11-02T13:18:56Z
dc.date.issued2022-03
dc.description.abstractMelanoma and non-melanoma skin cancers are the most-lethal and commonest forms of skin cancers, that affecting one-fifth of the US population. With the aim of identifying new lead compounds as starting point for attaining cost-effective therapies, a small library of about 90 molecules was screened in vitro against A375, SKMEL-28, A431, SCC-12 skin cancer cell lines. About 35 of them, mainly dihydroquinolines, C–C and C–N linked biphenyls, and substituted methylgallate or aniline derivatives, displayed lowmicromolar range activities, primarily against the A431 and SCC-12 squamous carcinoma cell lines, with only a handful of these compounds displaying any activity against the A375 and SKMEL-28 melanoma cell lines. Compounds 11 (A431: IC50 = 5.0 µM, SCC-12: IC50 = 2.9 µM, SKMEL-28: IC50 = 4.9 µM, A375: IC50 = 6.7 µM) and 13 (A431: IC50 = 5.0 µM, SCC-12: IC50 = 3.3 µM, SKMEL-28: IC50 = 13.8 µM, A375: IC50 = 17.1 µM) were the most active across all these cell lines. Furthermore, many of the hit compounds showed little to no activity against mammalian nontumorigenic immortalized HaCaT cells, with a far better selectivity index than cisplatin (a well-known anticancer agent used as a positive control). Compounds 11 and 13 significantly and dose-dependently induced apoptosis of SCC-12 and SK-MEL-28 cells as evidenced by the downregulation of Bcl-2 and upregulation of Bax protein expression levels, and by cleaved caspase3, caspase-9 and PARP levels. Both agents also significantly reduced scratch wound healing, colony formation, and activated expression levels of major cancer molecular targets such as RSK/AKT/ERK1/2 and S6K1. To provide a better attribute profile for each of the hit molecules, in-silico target(s) prediction, pharmacokinetic and ADMET studies are also reported, together with some preliminary structure-activity relationship outlines. The SwissTargetPrediction web-based tool identified CDK8, CLK4, nuclear receptor 2 ROR, tyrosine protein-kinase Fyn/LCK, ROCK1/2, and PARP, all of which are dysregulated in skin cancers, as likely targets for these hit compounds. Furthermore, the SwissADME web_tool predicted these compounds to exhibit high GI tract absorption, good skin permeation, and a viable biodegradability profile. To summarize, these data highlight the promising anticancer potential of these small molecules leads, warranting further investigation and/or optimization towards obtaining clinical candidates for combatting both melanoma and non-melanoma skin cancers.en
dc.identifier.urihttps://doi.org/10.1101/2022.02.28.482167
dc.identifier.urihttps://space.uenr.edu.gh/handle/123456789/129
dc.language.isoen
dc.relation.ispartofbioRxiv preprint (not certified by peer review)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectLibrary screening
dc.subjectMelanoma and non-melanoma skin cancer cells
dc.subjectAnti-cancer activity
dc.subjectApoptosis
dc.subjectIn silico target(s) prediction
dc.subjectPharmacokinetic and ADMET studies
dc.titleIdentification Of Potential Inhibitors Of Cutaneous Melanoma And Non-Melanoma Skin Cancer Cells Through In-Vitro And In-Silico Screening Of A Small Library Of Phenolic Compoundsen
dc.typePreprint

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022 - Identification of potential inhibitors of cutaneous Melanoma an.pdf
Size:
3.8 MB
Format:
Adobe Portable Document Format

Collections